Indications and uses
Uses For the relief of symptoms associated with psoriasis and or seborrheic dermatitis including itching, scaling, flaking, redness and irritation of the skin. Helps prevent recurrences. Treats eczema.
RevitaDERM PSORIASIS
- Manufacturer
- Blaine Labs Inc.
- Effective date
- 2023-12-21
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 4
- Source
- full-release
- Hydrated at
- 2026-06-01 00:05:21
Label at a glance#
ProductRevitaDERM PSORIASIS
Active ingredientCOAL TAR
Label structure9 sections
Dosage and administration
Directions Apply to affected areas as directed by a doctor. Apply as needed to affected areas as often as needed (up to four times per day)
Contacts and useful links#
Websitewww.drblaines.com
www.DrBlaines.com
www.DrBlaines.comLabel contents#
Full prescribing information#
Active Ingredients Section
Drug Facts Active Ingredient Coal Tar (2%)
Purpose Section
Purpose Psoriasis/Sebhorreic Dermatitis Treatment
Keep Out of Reach Of Children Section
Enter section text here
Uses Section
Uses For the relief of symptoms associated with psoriasis and or seborrheic dermatitis including itching, scaling, flaking, redness and irritation of the skin. Helps prevent recurrences.
Treats eczema.
Warnings Section
Warnings For external use only.
Ask a doctor before use For prolonged periods If condition covers a large area of the body Around the rectum or in the genital area or groin With other forms of psoriasis therapy such as ultraviolet radiation or prescription drugs.
Directions Section
Directions Apply to affected areas as directed by a doctor.
Apply as needed to affected areas as often as needed (up to four times per day)
Inactive Ingredient Section
Inactive Ingredients Colloidal Silver, Burdock Root, Tea Tree Oil, Lavender Oil, Chamomile Extract, Water, Xanthan Gum, Aloe 200X, Glycerin, Propylene Glycol, Safflower Oil, Dimethicone, C12/15 Alky Benzoate, Emulsifying Wax, Glycerol Stearate and PEG 100 Stearate, Cetyl Alcohol, Phenonip (phenoxyethanol, methylparaben, butylparaben, ethylparaben, propylparaben), Hydrocortisone, Triethanolamine.
Questions or Comments? Section
Questions or Comments? Call (800) 307-8818, Monday through Friday, 8:00 AM to 5:00 PM (Pacific Time)
Package Label Section
Dr. Blaine's RevitaDERM PSORIASIS TREATMENT
NDC #63347-112-01 08800-01 Rev 20111013
PROVEN FORMULA
Formulated specifically to address the many symptoms of psoriasis and eczema utilizing specially selected ingredients for maximum benefit.
Infused with the antimicrobial power of Colloidal Silver to help prevent infection.
Dr. Blaine's 800 307-8818 info@DrBlaines.com www.DrBlaines.com Blaine Labs, Inc. Santa Fe Springs, CA 90670
PREMIUM SKIN CARE PRODUCTS HELPS FIGHT INFECTION
Also Relieves Eczema Sebhorreic Dermatitis Itching Flaking More Powerful Faster Acting Reduce Odor DOCTOR DEVELOPED
4 fl. oz
OUR GUARANTEE 100% GUARANTEED Money Back Rick Free QUALITY PROMISE
RevitaDerm PSORIIASIS OINTMENT is guaranteed to temporarily help soothe and relieve the kin symptoms associated with psoriasis, eczema, and sebhorreic dermatitis to reduce itching, flaking, redness, and scaling.
Please Recycle! This package is made from recyclable materails. Proudly made in the U.S.A.
res
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 317080 | coal tar 2 % Topical Ointment | PSN | 4 |
| 1297944 | RevitaDERM PSORIASIS 2 % Topical Ointment | PSN | 4 |
| 1297944 | coal tar 0.02 MG/MG Topical Ointment [Revitaderm Psoriasis] | SBD | 4 |
| 317080 | coal tar 0.02 MG/MG Topical Ointment | SCD | 4 |
| 317080 | crude coal tar 2 % (coal tar solution 10 % ) Topical Ointment | SY | 4 |
| 1297944 | Revitaderm Psoriasis (coal tar 2 % ) Topical Ointment | SY | 4 |
| 1297944 | Revitaderm Psoriasis 0.02 MG/MG Topical Ointment | SY | 4 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 63347-112-01 | 2022-02-18 | C162847 | 48780-1 | d6a99b39-a091-a426-e053-dadaa90af4c2 | 06ad14d3-4ff4-4283-8197-8626aad3b8d0 |
| 63347-112-01 | 2022-01-28 | C162847 | 48780-1 | d6a99b39-a091-a426-e053-dadaa90af4c2 | 06ad14d3-4ff4-4283-8197-8626aad3b8d0 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63347-112-01 | RevitaDERM PSORIASIS | 118 mL in 1 JAR | OINTMENT | 118 | 4 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| COAL TAR | ACTIVE INGREDIENT | R533ESO2EC | 1 | |
| COAL TAR | ACTIVE MOIETY | R533ESO2EC | 1 | |
| ALKYL (C12-15) BENZOATE | INACTIVE INGREDIENT | A9EJ3J61HQ | 1 | |
| ALOE | INACTIVE INGREDIENT | V5VD430YW9 | 1 | |
| ARCTIUM LAPPA ROOT | INACTIVE INGREDIENT | 597E9BI3Z3 | 1 | |
| BUTYLPARABEN | INACTIVE INGREDIENT | 3QPI1U3FV8 | 1 | |
| CETOSTEARYL ALCOHOL | INACTIVE INGREDIENT | 2DMT128M1S | 1 | |
| CETYL ALCOHOL | INACTIVE INGREDIENT | 936JST6JCN | 1 | |
| CHAMAEMELUM NOBILE FLOWER | INACTIVE INGREDIENT | O2T154T6OG | 1 | |
| DIMETHICONE | INACTIVE INGREDIENT | 92RU3N3Y1O | 1 | |
| ETHYLPARABEN | INACTIVE INGREDIENT | 14255EXE39 | 1 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | 1 | |
| GLYCERYL MONOSTEARATE | INACTIVE INGREDIENT | 230OU9XXE4 | 1 | |
| HYDROCORTISONE | INACTIVE INGREDIENT | WI4X0X7BPJ | 1 | |
| LAVENDER OIL | INACTIVE INGREDIENT | ZBP1YXW0H8 | 1 | |
| METHYLPARABEN | INACTIVE INGREDIENT | A2I8C7HI9T | 1 | |
| PEG-100 STEARATE | INACTIVE INGREDIENT | YD01N1999R | 1 | |
| PHENOXYETHANOL | INACTIVE INGREDIENT | HIE492ZZ3T | 1 | |
| PROPYLENE GLYCOL | INACTIVE INGREDIENT | 6DC9Q167V3 | 1 | |
| PROPYLPARABEN | INACTIVE INGREDIENT | Z8IX2SC1OH | 1 | |
| SAFFLOWER OIL | INACTIVE INGREDIENT | 65UEH262IS | 1 | |
| SILVER | INACTIVE INGREDIENT | 3M4G523W1G | 1 | |
| TEA TREE OIL | INACTIVE INGREDIENT | VIF565UC2G | 1 | |
| TROLAMINE | INACTIVE INGREDIENT | 9O3K93S3TK | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 1 | |
| XANTHAN GUM | INACTIVE INGREDIENT | TTV12P4NEE | 1 |
Products#
Every source-derived product name is available through these pages.
- RevitaDERM PSORIASIS
- COAL TAR
- SILVER
- ARCTIUM LAPPA ROOT
- TEA TREE OIL
- LAVENDER OIL
- CHAMAEMELUM NOBILE FLOWER
- WATER
- XANTHAN GUM
- ALOE
- GLYCERIN
- PROPYLENE GLYCOL
- SAFFLOWER OIL
- DIMETHICONE
- ALKYL (C12-15) BENZOATE
- CETOSTEARYL ALCOHOL
- GLYCERYL MONOSTEARATE
- PEG-100 STEARATE
- CETYL ALCOHOL
- HYDROCORTISONE
- TROLAMINE
- PHENOXYETHANOL
- METHYLPARABEN
- BUTYLPARABEN
- ETHYLPARABEN
- PROPYLPARABEN
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 63347-112 | 63347-112-01 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| TROLAMINE | TROLAMINE | 9O3K93S3TK | SHAMPOO / TOPICAL | 3.7 %w/w | ||
| TROLAMINE | TROLAMINE | 9O3K93S3TK | AEROSOL, FOAM / TOPICAL | 2.6 %w/w | ||
| CETYL ALCOHOL | CETYL ALCOHOL | 936JST6JCN | OINTMENT / TOPICAL | 7 %w/w | ||
| PHENOXYETHANOL | PHENOXYETHANOL | HIE492ZZ3T | LOTION / TOPICAL | 1 %w/w | ||
| CETOSTEARYL ALCOHOL | CETOSTEARYL ALCOHOL | 2DMT128M1S | OINTMENT / TOPICAL | 1.2 %w/w | ||
| SAFFLOWER OIL | SAFFLOWER OIL | 65UEH262IS | LOTION / TOPICAL | 3510 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | OINTMENT / TOPICAL | NA | ||
| PHENOXYETHANOL | PHENOXYETHANOL | HIE492ZZ3T | GEL / TOPICAL | 14 mg | ||
| CETYL ALCOHOL | CETYL ALCOHOL | 936JST6JCN | OINTMENT / TOPICAL | 7 %w/w | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | OINTMENT / TOPICAL | 5148 mg | ||
| BUTYLPARABEN | BUTYLPARABEN | 3QPI1U3FV8 | OINTMENT / TOPICAL | 0.18 %w/w | ||
| TROLAMINE | TROLAMINE | 9O3K93S3TK | GEL / TOPICAL | 6 mg | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | CREAM / TOPICAL | 46 mg | ||
| PEG-100 STEARATE | PEG-100 MONOSTEARATE | YD01N1999R | CREAM / TOPICAL | 552 mg | ||
| ETHYLPARABEN | ETHYLPARABEN | 14255EXE39 | SUSPENSION / ORAL | 8 mg | ||
| CETOSTEARYL ALCOHOL | CETOSTEARYL ALCOHOL | 2DMT128M1S | OINTMENT / TOPICAL | 1.2 %w/w | ||
| PHENOXYETHANOL | PHENOXYETHANOL | HIE492ZZ3T | CREAM / TOPICAL | 57 mg | ||
| ETHYLPARABEN | ETHYLPARABEN | 14255EXE39 | SUSPENSION / ORAL | 8 mg | ||
| PHENOXYETHANOL | PHENOXYETHANOL | HIE492ZZ3T | CREAM / TOPICAL | 57 mg | ||
| PHENOXYETHANOL | PHENOXYETHANOL | HIE492ZZ3T | AEROSOL / TOPICAL | 1.05 %w/w | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | GEL / TOPICAL | 58 mg | ||
| PHENOXYETHANOL | PHENOXYETHANOL | HIE492ZZ3T | GEL / TOPICAL | 14 mg | ||
| ETHYLPARABEN | ETHYLPARABEN | 14255EXE39 | POWDER, FOR SOLUTION / ORAL | 13 mg | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | LOTION / TOPICAL | 0.3 %w/v | ||
| BUTYLPARABEN | BUTYLPARABEN | 3QPI1U3FV8 | OINTMENT / TOPICAL | 0.18 %w/w | ||
| TROLAMINE | TROLAMINE | 9O3K93S3TK | CREAM, AUGMENTED / TOPICAL | 20 mg | ||
| TROLAMINE | TROLAMINE | 9O3K93S3TK | GEL / TOPICAL | 6 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | OINTMENT / TOPICAL | 29 mg | ||
| ETHYLPARABEN | ETHYLPARABEN | 14255EXE39 | GRANULE, FOR SOLUTION / ORAL | 14 mg | ||
| TROLAMINE | TROLAMINE | 9O3K93S3TK | SOLUTION / TOPICAL | NA | ||
| PHENOXYETHANOL | PHENOXYETHANOL | HIE492ZZ3T | CREAM, AUGMENTED / TOPICAL | 10 mg | ||
| PEG-100 STEARATE | PEG-100 MONOSTEARATE | YD01N1999R | CREAM / TOPICAL | 552 mg | ||
| PROPYLENE GLYCOL | PROPYLENE GLYCOL | 6DC9Q167V3 | OINTMENT / TOPICAL | 5148 mg | ||
| SAFFLOWER OIL | SAFFLOWER OIL | 65UEH262IS | LOTION / TOPICAL | 3510 mg | ||
| TROLAMINE | TROLAMINE | 9O3K93S3TK | AEROSOL, FOAM / TOPICAL | 2.6 %w/w | ||
| PEG-100 STEARATE | PEG-100 MONOSTEARATE | YD01N1999R | LOTION / TOPICAL | 1 %w/w | ||
| TROLAMINE | TROLAMINE | 9O3K93S3TK | SPONGE / TOPICAL | 11 %w/w | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | OINTMENT / TOPICAL | 0.2 %w/w | ||
| ETHYLPARABEN | ETHYLPARABEN | 14255EXE39 | SOLUTION / ORAL | 14 mg | ||
| TROLAMINE | TROLAMINE | 9O3K93S3TK | SHAMPOO / TOPICAL | 3.7 %w/w | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | CREAM / TOPICAL | 46 mg | ||
| TROLAMINE | TROLAMINE | 9O3K93S3TK | LIQUID / TOPICAL | NA | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | AEROSOL, FOAM / TOPICAL | 0.27 %w/w | ||
| TROLAMINE | TROLAMINE | 9O3K93S3TK | LOTION / TOPICAL | 360 mg | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | OINTMENT / TOPICAL | 0.2 %w/w | ||
| ETHYLPARABEN | ETHYLPARABEN | 14255EXE39 | POWDER, FOR SOLUTION / ORAL | 13 mg | ||
| TROLAMINE | TROLAMINE | 9O3K93S3TK | SOLUTION / TOPICAL | NA | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | OINTMENT / TOPICAL | 5 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | OINTMENT / TOPICAL | NA | ||
| LAVENDER OIL | LAVENDER OIL | ZBP1YXW0H8 | GEL / TOPICAL | 0.1 %w/w | ||
| TROLAMINE | TROLAMINE | 9O3K93S3TK | SOAP / TOPICAL | 0.08 %w/w | ||
| TROLAMINE | TROLAMINE | 9O3K93S3TK | POWDER / TOPICAL | 0.02 mg/mg | ||
| TROLAMINE | TROLAMINE | 9O3K93S3TK | SOAP / TOPICAL | 0.08 %w/w | ||
| ETHYLPARABEN | ETHYLPARABEN | 14255EXE39 | SOLUTION / ORAL | 14 mg | ||
| TROLAMINE | TROLAMINE | 9O3K93S3TK | GEL, METERED / TOPICAL | 20 mg | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | SUSPENSION / TOPICAL | 0.11 %w/v | ||
| PHENOXYETHANOL | PHENOXYETHANOL | HIE492ZZ3T | AEROSOL, FOAM / TOPICAL | 72 mg | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | GEL / TOPICAL | 58 mg | ||
| TROLAMINE | TROLAMINE | 9O3K93S3TK | LOTION / TOPICAL | 360 mg | ||
| TROLAMINE | TROLAMINE | 9O3K93S3TK | POWDER / TOPICAL | 0.02 mg/mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| RevitaDERM PSORIASIS | COAL TAR | Blaine Labs Inc. | 06ad14d3-4ff4-4283-8197-8626aad3b8d0 | 2023-12-21 | Warnings | 63347-112-01 63347-112 63347011201 52aacff7-6265-4446-9dd0-dfef99dd4785 06ad14d3-4ff4-4283-8197-8626aad3b8d0 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.